Investors

2025 first quarter announcement

We announced our first quarter 2025 results on Wednesday 30 April. Access our first quarter results and latest Annual Report below.

We’re confident in our future

With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide.

Speeches and presentations

Tony Wood

Citi European Healthcare Conference, London

17 June 2025

Tony Wood, Chief Scientific Officer, attended the Citi European Healthcare Conference in London on Tuesday, 17 June 2025.

Dr Kimberly Smith

Goldman Sachs Global Healthcare Conference

09 June 2025

Kimberly Smith, Head of R&D at ViiV Healthcare, attended the Goldman Sachs Global Healthcare Conference in Miami on Monday, 9 June 2025.

David Redfern

NYSE Health Care Virtual Investor Access Day

05 June 2025

David Redfern, President Corporate Development, attended the NYSE Health Care Virtual Investor Access Day on Thursday, 5 June 2025.

Julie Brown sat on a grey sofa smiling

BNP Paribas Exane CEO Conference

05 June 2025

Julie Brown, Chief Financial Officer, attended the BNP Paribas Exane CEO Conference in Paris on Thursday, 5 June 2025.

David Redfern

Goldman Sachs Biopharma Innovation Summit

27 March 2025

David Redfern, President, Corporate Development, attended the Goldman Sachs Biopharma Innovation Summit in London on Thursday, 27 March 2025.

GSK share price

Share price tool

Detailed information on GSK's share price, including an interactive chart

Behind the science

Read our latest articles

Behind the science magazine
two scientists talking

Get in touch with our investor team

_